antineoplaston a10 has been researched along with zstk474 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Gao, Z; Ge, T; Gong, P; Hou, Y; Liu, J; Liu, Y; Tang, J; Wang, S; Wang, Y; Xu, J; Zhao, Y | 1 |
1 other study(ies) available for antineoplaston a10 and zstk474
Article | Year |
---|---|
Based on 2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole (ZSTK474), design, synthesis and biological evaluation of novel PI3Kα selective inhibitors.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Humans; Mice; Phosphoinositide-3 Kinase Inhibitors; Structure-Activity Relationship; Triazines | 2023 |